article thumbnail

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

726/2004, 09 March 2021. 726/2004 , which essentially means duplicate MAAs for products authorized via the centralized procedure. World Health Organization (WHO). EC Issues Notice on the Handling of Duplicate Marketing Authorization Applications (MAAs) of Pharmaceutical Products under Article 82(1) of Regulation (EC) No.